pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
6,918
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
N-acetyl cysteine amide
Retinitis Pigmentosa (Retinitis)
Nacuity Pharmaceuticals Inc
N/A
N/A (ATROPINE INJECTION, 2 MG)
no indication
RAFA LABS LTD
Phase 2
NA-704
Amyotrophic Lateral Sclerosis
Biomed Industries Inc
Phase 1
← prev
page 111 of 231
next →
131
Pain
89
Neurology
1
NA-731
Traumatic Brain Injury
Biomed Industries Inc
Phase 3
NA-831
Traneurocin
Alzheimer's Disease
Biomed Industries Inc
Phase 3
NA-921
Rett Syndrome
Biomed Industries Inc
Phase 2
NA-931
Obesity
Biomed Industries Inc
Phase 3
NA-941
Metabolic Dysfunction-Associated Steatohepatitis (MASH or…
Biomed Industries Inc
Preclinical
NAFL Diseases
Metabolic Dysfunction-Associated Steatotic Liver Disease…
Metallomix Inc
NALMEFENE HYDROCHLORIDE
NALMEFENE HYDROCHLORIDE
no indication
Purdue Pharma LP
NAPROXEN AND ESOMEPRAZOLE MAGNESIUM
NAPROXEN AND ESOMEPRAZOLE MAGNESIUM
no indication
Ajanta Pharma Ltd
NAPROXEN ORAL SUSPENSION
NAPROXEN ORAL SUSPENSION (NAPROXEN ORAL)
no indication
NOVITIUM PHARMA
NAPROXEN SODIUM AND DIPHENHYDRAMINE HCL
NAPROXEN SODIUM AND DIPHENHYDRAMINE HCL
no indication
GRANULES
Phase 1
NAS-150
Idiopathic Pulmonary Fibrosis
New Amsterdam Sciences Inc
Phase 2
NB-001
DiGeorge Syndrome
Nobias Therapeutics Inc
Phase 2
NB-003
Gastrointestinal Stromal Tumor (GIST)
NewBay Medical Technology Co Ltd
Preclinical
NBIB-233
Parkinson's Disease
$VYGR
Voyager Therapeutics, Inc.
Preclinical
NBIP-2118
Obesity
$NBIX
NEUROCRINE BIOSCIENCES INC
Phase 2
NBM-BMX
Metastatic Uveal Melanoma
Novelwise Pharmaceutical Corp
Phase 1
NC-2400
Dyslipidemia
ABIONYX Pharma SA
Phase 2
NC-410
Cervical Cancer
$NXTC
NextCure, Inc.
Preclinical
NC-605
Osteogenesis Imperfecta
$NXTC
NextCure, Inc.
Preclinical
NCEs
Unspecified Respiratory Disorders
Chiesi USA Inc
Phase 2
NCS-01
Acute Ischemic Stroke
NC Medical Research Inc
Phase 2
ND-10 ER
Myopia
Theialife Sciences Pvt Ltd
Preclinical
NDC-1308
Alzheimer's Disease
Endece LLC
Preclinical
NDI-5001
Kidney Disease (Nephropathy)
NephroDI Therapeutics Inc
NEBIVOLOL
NEBIVOLOL
no indication
HETERO LABS LTD III
Preclinical
NED-170
Bile Duct Cancer (Cholangiocarcinoma)
NED Biosystems Inc
Phase 2
NEO-100
Recurrent Glioblastoma Multiforme (GBM)
$NTHI
NEONC TECHNOLOGIES HOLDINGS, INC.
